BAX''s Novum IQ Large Volume Pumps are playing a key role in driving topline progress, whilst the HST division too looks set to benefit from a few tailwinds.

https://www.investing.com/news/stock-market-news/earnings-call-baxter-international-exceeds-q2-expectations-raises-outlook-93CH-3558160

Baxter International Inc. (NYSE:NYSE:BAX) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ETCompany ParticipantsClare Trachtman - Senior Vice…

Baxter Intl (NYSE: BAX ) just reported results for the second quarter of 2024. Baxter Intl reported earnings per share of 68 cents. This was above the analyst estimate for EPS of 66 cents. The company reported revenue of $3.81 billion. This was 1.65% better than the analyst estimate for revenue of $3.75 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace .

On Tuesday, Baxter International Inc (NYSE: BAX ) reported second-quarter adjusted EPS of $0.68, beating the consensus of $0.66 and the management guidance of $0.65-$0.67 . The company reported sales of $3.812 billion, which beat the consensus of $3.755 billion . Sales increased 3% on a reported basis and 4% on a constant currency basis, exceeding the company’s previously issued guidance of approximately 1% and 2% to 3%, respectively. Related: Carlyle’s $4B Purchase Of Baxter’s Kidney Division Backed By Ares And HPS Financing . Baxter achieved better-than-expected sales growth across all segments in the second quarter at constant currency . Pharmaceuticals segment sales increased 11% to $602 million, driven by the ongoing impact of new product … Full story available on Benzinga.com

The following slide deck was published by Baxter International Inc.

DEERFIELD (dpa-AFX) - While reporting financial results for the second quarter on Tuesday, health care company Baxter International Inc. (BAX) raised its earnings, adjusted earnings and sales grow…

DEERFIELD (dpa-AFX) - Below are the earnings highlights for Baxter International Inc. (BAX):Earnings: -$314 million in Q2 vs. -$141 million in the same period last year. EPS: -$0.62 in Q2 vs. -$0….

Heightened volatility on Wall Street means contrarian stock picks can be a game-changer for savvy investors. A contrarian investing strategy involves buying overlooked assets with the expectation that they will eventually increase in value. This article highlights three picks that may defy current trends and offer significant upside potential. While many follow the herd, those willing to explore less-traveled paths often discover hidden opportunities. Warren Buffett is widely recognized as one of the most successful investors of all time. His investment philosophy, which often goes against prevailing market trends, epitomizes contrarian investing. His conglomerate holding company Berkshire Hathaway (NYSE: BRK-A , NYSE: BRK-B ) has recently sold about half of its holdings in Apple (NASDAQ: AAPL ) stock, among others. In other words, he has gone against investors who have been cheering mega-cap tech shares despite high valuation levels. Yet, contrarian investing is not for the faint-hearted; it demands a sharp eye for undervalued assets and the ability to ride out market fluctuations.

Earnings To Watch: Baxter International Inc (BAX) Reports Q2 2024 Result